ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 77 filers reported holding ORIC PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $903,912 | +30.2% | 149,407 | +67.0% | 0.00% | – |
| Q2 2023 | $694,326 | -9.7% | 89,475 | -33.7% | 0.00% | – |
| Q1 2023 | $768,947 | -1.0% | 134,903 | +2.3% | 0.00% | – |
| Q4 2022 | $776,496 | +12.0% | 131,833 | -39.1% | 0.00% | – |
| Q3 2022 | $693,000 | -70.9% | 216,537 | -59.2% | 0.00% | – |
| Q2 2022 | $2,380,000 | +12.7% | 531,287 | +34.3% | 0.00% | – |
| Q1 2022 | $2,112,000 | +555.9% | 395,487 | +2471.9% | 0.00% | – |
| Q3 2021 | $322,000 | -5.8% | 15,377 | -20.4% | 0.00% | – |
| Q2 2021 | $342,000 | -75.0% | 19,315 | -52.2% | 0.00% | – |
| Q4 2020 | $1,369,000 | -18.6% | 40,435 | -39.8% | 0.00% | – |
| Q3 2020 | $1,681,000 | +630.9% | 67,207 | +883.9% | 0.00% | – |
| Q2 2020 | $230,000 | – | 6,831 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,007,576 | $25,199,000 | 12.12% |
| Svennilson Peter | 4,768,181 | $119,252,000 | 9.73% |
| EcoR1 Capital, LLC | 2,642,218 | $66,082,000 | 4.71% |
| Orbimed Advisors | 2,921,967 | $73,078,000 | 0.92% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 312,483 | $7,815,000 | 0.35% |
| EMERALD ADVISERS, LLC | 324,582 | $8,118,000 | 0.33% |
| Casdin Capital, LLC | 251,515 | $6,290,000 | 0.28% |
| ArrowMark Colorado Holdings LLC | 995,382 | $24,895,000 | 0.24% |
| Artal Group S.A. | 142,500 | $3,564,000 | 0.09% |
| Alyeska Investment Group, L.P. | 161,585 | $4,041,000 | 0.06% |